Bottom line
What is MEDIX's expense ratio?
MEDIX's expense ratio is 0.82%, or about $82 a year on every $10,000 invested. That is cheaper than 65% of emerging-markets bond funds we track (median 0.92%). It has no front-end sales load.
Updated Nov 26, 2025
MEDIX fee table
| Net expense ratio | 0.82% |
|---|---|
| Gross expense ratio | 0.83% |
| Management fee | 0.67% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.16% |
| Fee waiver / reimbursement | -0.01% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Nov 26, 2025
What MEDIX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| MEDIX | $84 | $264 | $460 | $1,024 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.82% expense ratio costs roughly $46,100 in lost growth, versus about $51,300 for the median emerging-markets bond fund (0.92%).